volume 2, issue 8, PS466-S467 2007
DOI: 10.1097/01.jto.0000283412.15497.33
View full text
|
|
Share

Abstract: Materials and Methods: Enrollees received Cb AUC 6 day 1 in combination with Pac 100 mg/m 2 days 1, 8, and 15 every 4 weeks, and C225 at a loading dose of 400 mg/m 2 day 1, then 250 mg/m 2 weekly thereafter. C225 was continued as a single agent after 6 full cycles of therapy in patients without disease progression or limiting toxicity. Eligibility stipulated advanced NSCLC (Stage IV, "wet" and IIIB or recurrence after prior surgery/radiation); ECOG performance status 0-1; measurable tumor, and adequate physiol…

Expand abstract

Search citation statements

Order By: Relevance

Citation Types

0
0
0

Paper Sections

0
0
0
0
0

Publication Types

0
0
0
0

Relationship

0
0

Authors

Journals